Nantakarn Pongtarakulpanit

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Abatacept for the treatment of myositis-associated interstitial lung disease”.

Abatacept for the treatment of myositis-associated interstitial lung disease

Lara D. Veeken(2025)10.1093/rheumatology/keaf218

N/A

0.281DataRank · unranked

4 citations

Nantakarn Pongtarakulpanit, Daniel I. Sullivan, Siamak Moghadam‐Kia, Sangmee Bae, Jesse Wilkerson +15 more

Disease characteristics and medications use in idiopathic inflammatory myopathy: a multi-centre prospective observational study of decentralized remote vs. traditional clinic enrolment

Lara D. Veeken(2024)10.1093/rheumatology/keae467

N/A

0DataRank · unranked

1 citations

Raisa Lomanto Silva, Tanya Chandra, E. Gkiaouraki, Nantakarn Pongtarakulpanit, Shreya Sriram +4 more

Recruitment rate comparison between a virtual tele-research cohort and a traditional centre-based cohort in idiopathic inflammatory myopathy

Lara D. Veeken(2025)10.1093/rheumatology/keaf217

N/A

0DataRank · unranked

0 citations

Anushka Aggarwal, Swamy R. Venuturupalli, Shiri Keret, Nantakarn Pongtarakulpanit, Mark Riley +90 more

Validation of simplified scoring systems for assessing cutaneous disease activity in dermatomyositis

Clinical and Experimental Rheumatology(2025)10.55563/clinexprheumatol/8lq4aq

N/A

0DataRank · unranked

0 citations

Anuradha Bishnoi, Tanya Chandra, Sedin Dzanko, E. Gkiaouraki, Shiri Keret +9 more